Records containing: Neurotrophic Keratopathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (SEER-2)
-
CLINICAL_TRIALS study record update · 2024-12-02A Prospective, Multicenter Trial to Evaluate Efficacy and Safety of Cenegermin-bkbj (20 mcg/mL) Ophthalmic Solution on Corneal Thickness Via Anterior Segment Optical Coherence Tomography (AS-OCT) in Stage 3 Neurotrophic Keratitis
-
CLINICAL_TRIALS study record update · 2024-05-14Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
-
CLINICAL_TRIALS study record update · 2024-05-08Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy
-
CLINICAL_TRIALS study record update · 2024-05-07A Phase 2, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray in Subjects With Neurotrophic Keratopathy (the Olympia Study)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-26Topical Insulin in Treatment of Neurotrophic Corneal Ulcer,Efficacy And Safety
-
CLINICAL_TRIALS study record update · 2023-08-14Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy: SEER-1
-
CLINICAL_TRIALS study record update · 2020-10-27A Multicenter, Randomized, Open-label, Two-arms Phase I/II Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy
-
CLINICAL_TRIALS study record update · 2020-03-05In Vivo Evaluation of Corneal Nerves and Epithelial Healing After Treatment With Nerve Growth Factor for Neurotrophic Keratopathy